首页/数据集/Supplementary Tables from Distant Metastases of Breast Cancer Resemble Primary Tumors in Cancer Cell Composition but Differ in Immune Cell Phenotypes

Supplementary Tables from Distant Metastases of Breast Cancer Resemble Primary Tumors in Cancer Cell Composition but Differ in Immune Cell Phenotypes

NIAID Data Ecosystem2026-05-02 收录

乳腺癌转移分析

肿瘤免疫微环境

数据链接：

https://figshare.com/articles/dataset/Supplementary_Tables_from_Distant_Metastases_of_Breast_Cancer_Resemble_Primary_Tumors_in_Cancer_Cell_Composition_but_Differ_in_Immune_Cell_Phenotypes/28122811 数据链接链接失效反馈

官方服务：

资源简介：

Supplementary Tables 1-9

应用场景：

创建时间：

2025-01-02

胃癌预后模型

肿瘤免疫微环境

Gastric cancer (GC) is one of the most common malignant gastrointestinal tumors worldwide. Pyroptosis was widely reported to exert a crucial function in tumor development. In addition, pyroptosis was

NIAID Data Ecosystem10

DataSheet_1_Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer.zip

结直肠癌分子亚型

肿瘤免疫微环境

BackgroundCompared to other subtypes, the CMS4 subtype is associated with lacking of effective treatments and poorer survival rates. MethodsA total of 24 patients with CRC were included in this study.

NIAID Data Ecosystem00

Supplementary Table S1 from The Breast Tumor Immune Microenvironment of DNA Double-Strand Break Repair Pathogenic Variant Carriers Is Enriched with Tumor-Associated Macrophages

肿瘤免疫微环境

DNA修复变异

Supplementary Table S1: Unadjusted regression model results for carrier status association with immune features

Figshare2025-06-03 更新00

肿瘤免疫微环境

结直肠癌肝转移预后标志物

This record contains raw data related to article “Intrahepatic CD69 + Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression" Abstract

Zenodo2023-01-03 更新10

DataSheet_1_RETRACTED: The Collective Effect of MIP-3α and FL Promotes Dendritic Cell Function Within the Immune Microenvironment of Murine Liver Cancer.docx

肿瘤免疫微环境

肝细胞癌免疫治疗

Hepatocellular carcinoma is a highly malignant and lethal tumor. In addition to surgery, immunotherapy is currently a more effective treatment for hepatocellular carcinoma. The tumor immune microenvir

NIAID Data Ecosystem00